Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$168M |
| 2 |
Exxon Mobil
XOM
|
$120M |
| 3 |
GE HealthCare
GEHC
|
$103M |
| 4 |
Visa
V
|
$96.1M |
| 5 |
Meta Platforms (Facebook)
META
|
$92.1M |
Top Sells
| 1 |
Walmart
WMT
|
$331M |
| 2 |
JPMorgan Chase
JPM
|
$199M |
| 3 |
GE Aerospace
GE
|
$102M |
| 4 |
Thermo Fisher Scientific
TMO
|
$98.9M |
| 5 |
ConocoPhillips
COP
|
$80.4M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.08% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
PDS Biotechnology
PDSB
$56.4M
| $337K | ﹤0.01% |
54,720
-3,550
| -6% | -$21.8K |
|
3102
Lindblad Expeditions
LIND
$803M
| $334K | ﹤0.01% |
34,956
-14,254
| -29% | -$136K |
|
3103
ImmuCell
ICCC
$57.3M
| $333K | ﹤0.01% |
64,689
+2,519
| +4% | +$13K |
|
3104
Smith Micro Software
SMSI
$15.5M
| $332K | ﹤0.01% |
35,803
-9,878
| -22% | -$91.7K |
|
|
EFXT
3105
Enerflex
EFXT
$1.22B
| $331K | ﹤0.01% |
55,626
+751
| +1% | +$4.47K |
|
3106
Savara
SVRA
$643M
| $331K | ﹤0.01% |
169,509
+88,101
| +108% | +$172K |
|
|
DM
3107
DELISTED
Desktop Metal, Inc.
DM
| $329K | ﹤0.01% |
14,339
| – | – |
|
|
FLNT
3108
Fluent
FLNT
$53.1M
| $327K | ﹤0.01% |
66,518
-18,481
| -22% | -$90.9K |
|
|
WMPN
3109
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $319K | ﹤0.01% |
28,181
| – | – |
|
3110
Alpha Pro Tech
APT
$51.2M
| $316K | ﹤0.01% |
75,911
| – | – |
|
|
FSR
3111
DELISTED
Fisker Inc.
FSR
| $315K | ﹤0.01% |
51,354
| – | – |
|
|
NSTG
3112
DELISTED
NanoString Technologies, Inc.
NSTG
| $315K | ﹤0.01% |
31,792
-710
| -2% | -$7.03K |
|
|
ATYR
3113
aTyr Pharma
ATYR
$550M
| $310K | ﹤0.01% |
147,773
-49,919
| -25% | -$105K |
|
3114
Willamette Valley Vineyards
WVVI
$24.3M
| $310K | ﹤0.01% |
50,325
-1,158
| -2% | -$7.13K |
|
3115
Copel
ELP
$6.77B
| $309K | ﹤0.01% |
57,658
| – | – |
|
3116
Avalon Holdings
AWX
$9.59M
| $308K | ﹤0.01% |
116,205
| – | – |
|
3117
HF Foods Group
HFFG
$170M
| $306K | ﹤0.01% |
78,150
-45,014
| -37% | -$176K |
|
|
AKTS
3118
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $304K | ﹤0.01% |
98,696
+10,962
| +12% | +$33.8K |
|
3119
NextCure
NXTC
$13M
| $304K | ﹤0.01% |
17,102
-10,326
| -38% | -$183K |
|
3120
Lemonade
LMND
$3.71B
| $303K | ﹤0.01% |
21,266
+1,874
| +10% | +$26.7K |
|
3121
Smith-Midland
SMID
$222M
| $301K | ﹤0.01% |
16,053
-1,532
| -9% | -$28.7K |
|
3122
Bank First Corp
BFC
$1.26B
| $300K | ﹤0.01% |
4,079
+260
| +7% | +$19.1K |
|
|
CBD
3123
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $299K | ﹤0.01% |
101,617
| – | – |
|
|
PMD
3124
DELISTED
Psychemedics Corporation
PMD
| $297K | ﹤0.01% |
56,562
-2,354
| -4% | -$12.4K |
|
3125
Zevra Therapeutics
ZVRA
$502M
| $296K | ﹤0.01% |
53,882
+1,144
| +2% | +$6.29K |
|